Generic drug quality control uses strict cGMP standards, serialization, and advanced testing to prevent counterfeit medicines. Learn how these systems protect patients and why compliance matters.
Learn how to check for pharmacy-level drug recall notifications using FDA alerts, wholesaler systems, and pharmacy software. Essential steps for 2025 to ensure patient safety and avoid legal risk.
Many patients take separate generic pills instead of fixed-dose combinations for flexibility or cost. But this practice carries hidden risks-missed doses, drug interactions, and lack of safety testing. Learn when it's safe-and when it's not.
Population pharmacokinetics uses real-world patient data to prove drug equivalence across diverse populations, replacing traditional bioequivalence studies in many cases. Learn how it works, why regulators accept it, and where it's headed.
Generic drug shortages aren't caused by lack of manufacturers - they're caused by too many companies chasing low-margin pills and none willing to make complex, essential drugs. Here's why the system is breaking - and what can be done.
Learn how to build a safe, simple medication schedule that prevents dangerous drug interactions. Use proven methods like the Universal Medication Schedule, pill organizers, and pharmacist reviews to stay healthy and avoid hospital visits.
Complex generic drugs face major scientific and regulatory hurdles that make approval far harder than for simple generics. Despite high demand and patent expirations, few reach the market due to technical challenges, unclear FDA guidance, and high development costs.
Keeping an accurate list of all your medications - including supplements and OTC drugs - can prevent dangerous interactions and save your life. Learn how to build, update, and use your list for safer care.
Chemotherapy remains a cornerstone of cancer treatment, but drug interactions can be dangerous. Learn how common medications, supplements, and genetics affect chemo safety and effectiveness.
Discover how much money the U.S. saves each year thanks to FDA-approved generic drugs, with a detailed year-by-year breakdown of savings from new approvals and total market impact.